NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 341 filers reported holding NEKTAR THERAPEUTICS in Q2 2019. The put-call ratio across all filers is 2.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,658 | +1.2% | 38,042 | -2.3% | 0.00% | – |
| Q2 2023 | $22,396 | -18.2% | 38,936 | 0.0% | 0.00% | – |
| Q1 2023 | $27,368 | -70.3% | 38,936 | -4.5% | 0.00% | – |
| Q4 2022 | $92,176 | -81.7% | 40,786 | -74.1% | 0.00% | -100.0% |
| Q3 2022 | $503,000 | -24.4% | 157,178 | -10.2% | 0.00% | -33.3% |
| Q2 2022 | $665,000 | -46.8% | 174,954 | -24.6% | 0.00% | -25.0% |
| Q1 2022 | $1,251,000 | -83.1% | 232,041 | -57.7% | 0.00% | -82.6% |
| Q4 2021 | $7,407,000 | -35.9% | 548,273 | -14.8% | 0.02% | -41.0% |
| Q3 2021 | $11,557,000 | +68.1% | 643,473 | +60.6% | 0.04% | +62.5% |
| Q2 2021 | $6,876,000 | -31.6% | 400,702 | -20.3% | 0.02% | -36.8% |
| Q1 2021 | $10,054,000 | +122.6% | 502,713 | +89.2% | 0.04% | +123.5% |
| Q4 2020 | $4,517,000 | -1.0% | 265,680 | -3.4% | 0.02% | -10.5% |
| Q3 2020 | $4,561,000 | -24.7% | 274,927 | +5.1% | 0.02% | -34.5% |
| Q2 2020 | $6,061,000 | +37.0% | 261,689 | +5.6% | 0.03% | +3.6% |
| Q1 2020 | $4,423,000 | -28.5% | 247,761 | -13.6% | 0.03% | -12.5% |
| Q4 2019 | $6,188,000 | +18.5% | 286,691 | +0.0% | 0.03% | +6.7% |
| Q3 2019 | $5,222,000 | -40.0% | 286,681 | +17.2% | 0.03% | -40.0% |
| Q2 2019 | $8,703,000 | +15.7% | 244,610 | +9.3% | 0.05% | +8.7% |
| Q1 2019 | $7,520,000 | +8.1% | 223,808 | +5.7% | 0.05% | -9.8% |
| Q4 2018 | $6,958,000 | -43.4% | 211,691 | +4.9% | 0.05% | -32.0% |
| Q3 2018 | $12,304,000 | +26.1% | 201,838 | +1.0% | 0.08% | +13.6% |
| Q2 2018 | $9,755,000 | -52.4% | 199,774 | +3.5% | 0.07% | -54.5% |
| Q1 2018 | $20,504,000 | +2.2% | 192,958 | -42.6% | 0.14% | +6.6% |
| Q4 2017 | $20,072,000 | +137.8% | 336,108 | -4.4% | 0.14% | +115.9% |
| Q3 2017 | $8,439,000 | +34.0% | 351,645 | +9.1% | 0.06% | +34.0% |
| Q2 2017 | $6,300,000 | +52.8% | 322,257 | +2.7% | 0.05% | +42.4% |
| Q1 2017 | $4,124,000 | +0.1% | 313,746 | -6.6% | 0.03% | -10.8% |
| Q4 2016 | $4,121,000 | -30.4% | 335,851 | -2.6% | 0.04% | -28.8% |
| Q3 2016 | $5,924,000 | +32.1% | 344,811 | +9.4% | 0.05% | +23.8% |
| Q2 2016 | $4,484,000 | +2.1% | 315,129 | -1.4% | 0.04% | +2.4% |
| Q1 2016 | $4,393,000 | -20.9% | 319,510 | -3.0% | 0.04% | -21.2% |
| Q4 2015 | $5,552,000 | +61.8% | 329,545 | +5.3% | 0.05% | +73.3% |
| Q3 2015 | $3,431,000 | -14.1% | 313,060 | -1.9% | 0.03% | +400.0% |
| Q2 2015 | $3,992,000 | +25.5% | 319,105 | +10.3% | 0.01% | +20.0% |
| Q1 2015 | $3,182,000 | -36.4% | 289,290 | -10.4% | 0.01% | -37.5% |
| Q4 2014 | $5,004,000 | +6.6% | 322,845 | -17.0% | 0.01% | 0.0% |
| Q3 2014 | $4,693,000 | +6.7% | 388,860 | +13.3% | 0.01% | +14.3% |
| Q2 2014 | $4,400,000 | +1.1% | 343,257 | -4.5% | 0.01% | 0.0% |
| Q1 2014 | $4,354,000 | +7.9% | 359,287 | +1.0% | 0.01% | 0.0% |
| Q4 2013 | $4,037,000 | -8.7% | 355,792 | -16.0% | 0.01% | -12.5% |
| Q3 2013 | $4,422,000 | +10.9% | 423,407 | +22.7% | 0.01% | 0.0% |
| Q2 2013 | $3,987,000 | – | 345,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |